Luminor Registry: Registry of the Results of Angioplasty With Drug-eluting Balloon (Paclitaxel) in the Treatment of Infrainguinal Occlusive Lesions and Restenosis From Prior Endovascular Procedures in This Sector.

Inclusion Criteria: * Patients of both sexes aged at least 18 * Primary injuries and restenosis of the infrainguinal sector of AFS, AP and ATs, and intrastent restenosis or post-ATP prior in that sector. * Stenosis \>50% and occlusions. (image test) * Length: 20 to 200 mm * Artery diameter: 2-7 mm. * Symptomatic patients (grades 2-5 Rutherford-Baker both included; Fontaine II-IV), affected in their quality of life and that accept treatment (moderate / severe claudication patients, critical ischemia without gangrene or injuries severe enough to foresee limb amputation). Exclusion Criteria: * Patients with acute or subacute ischemia will be excluded. * Existence of flow-limiting lesions in arteries of the "in flow" or the "out flow" of the sector or artery under treatment (\> 50 % of the arterial diameter). * Aneurysmal dilatation in the ipsilateral arterial axis. * Intolerance / allergy to heparin, thienopyridine derivatives (clopidogrel , ticlopidine) and aspirin. * Hemorrhagic diathesis during the 3 months prior to inclusion. * Patients with a life expectancy of less than 12 months. * Serious allergy to contrasts or PTX. * Inability to cross the lesion with the guide (these cases will be recorded for the analysis as "intention to treat). * Those participating simultaneously in another clinical trial. * Pregnancy or lactation (pregnancy tests on fertiles).